The estimated Net Worth of Michael J Shoup is at least 192 千$ dollars as of 20 November 2009. Michael Shoup owns over 3,500 units of Surmodics stock worth over 111,845$ and over the last 19 years Michael sold SRDX stock worth over 80,150$.
Michael has made over 1 trades of the Surmodics stock since 2009, according to the Form 4 filled with the SEC. Most recently Michael sold 3,500 units of SRDX stock worth 80,150$ on 20 November 2009.
The largest trade Michael's ever made was selling 3,500 units of Surmodics stock on 20 November 2009 worth over 80,150$. On average, Michael trades about 500 units every 0 days since 2006. As of 20 November 2009 Michael still owns at least 2,851 units of Surmodics stock.
You can see the complete history of Michael Shoup stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 9924, West 74th Street, Eden Prairie, Hennepin County, Minnesota, 55344, United States of America.
Over the last 21 years, insiders at Surmodics have traded over 26,204,565$ worth of Surmodics stock and bought 19,725 units worth 436,251$ . The most active insiders traders include Jeffrey C Smith、Gary R Maharaj、Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of 415,014$. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth 706,662$.
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
Surmodics executives and other stock owners filed with the SEC include: